New Anticoagulants for Atrial Fibrillation

The authors regret the following two errors published in the above article in Seminars in Thrmbosis and Hemostasis, Volume 35, Number 5: On page 515, line five of the abstract, “These drugs have minimal protein binding and predictable pharmacokinetics that allow fixed dosing without laboratory monitoring and are being compared with vitamin K antagonists or aspirin in phase III clinical trials”, is incorrect. This line should read “These drugs …